Contents XVII. List of Contributors Preface XXIII
|
|
- Adela Wilkins
- 5 years ago
- Views:
Transcription
1 V List of Contributors Preface XXIII XVII 1 Proteins Separation and Purification by Expanded Bed Adsorption and Simulated Moving Bed Technology 1 Ping Li, Pedro Ferreira Gomes, José M. Loureiro, and Alirio E. Rodrigues 1.1 Introduction Protein Capture by Expanded Bed Technology Adsorbent Materials Expanded Bed Adsorption/Desorption of Protein Modeling of the Expanded Bed Proteins Separation and Purification by Salt Gradient Ion Exchange SMB Adsorption Isotherms and Kinetics of BSA and Myoglobin on Ion Exchange Resins Salt Gradient Formation and Process Design for IE-SMB Chromatography Separation Region of Salt Gradient IE-SMB Chromatography Proteins Separation and Purification in Salt Gradient IE-SMB with Open Loop Configuration Conclusion 26 References 27 2 BioSMB Technology as an Enabler for a Fully Continuous Disposable Biomanufacturing Platform 35 Marc Bisschops 2.1 Introduction Integrated Continuous Bioprocessing Multicolumn Chromatography 39
2 VI 2.4 BioSMB Technology Fully Disposable Continuous Processing Case Studies Regulatory Aspects Conclusions 50 References 51 3 Impact of Continuous Processing Techniques on Biologics Supply Chains 53 Aloke Das 3.1 Introduction The Biologics Industry The Biologics Value Chain Downstream Purification Costs Chromatography Techniques Used in Downstream Purification of Biomolecules Need for Continuous Manufacturing in Downstream Purification The Multicolumn Countercurrent Solvent Gradient Purification Chromatography System Next-Generation Biologic Products Bispecific Monoclonal Antibodies Major Biopharma Companies and Their Interest in Bispecific Mabs Challenges in Purification of Bispecific Monoclonal Antibodies Improving the Downstream Processing of Bispecific Mabs by Introduction of MCSGP in the Value Chain Advantages of Utilizing MCSGP Process in Bispecific Mabs Purification as Compared to Batch Chromatography Impact of MCSGP System on Biologic Supply Chains Impact on Patent Approval Structure of Biologic Drugs For a Manufacturer Who Already has a Biologic Drug in the Market For a Manufacturer Who is Developing a Biologic Drug Impact on Big Biopharma Companies Impact on the Chromatography Market Limitations of the MCSGP System Conclusion Further Research 65 Acknowledgments 66 3.A Appendix/Additional Information 66 3.A.1 Regulatory Structure for Bispecific Monoclonal Antibodies 67 3.A.1.1 Regulatory Compliance Comparison between US, EU, and Emerging Economies 67 References 68
3 VII 4 Integrating Continuous and Single-Use Methods to Establish a New Downstream Processing Platform for Monoclonal Antibodies 71 Christopher Gillespie, Mikhail Kozlov, Michael Phillips, Ajish Potty, Romas Skudas, Matthew Stone, Alex Xenopoulos, Alison Dupont, Jad Jaber, and William Cataldo 4.1 Introduction Harvest and Clarification The Challenge and Technology Selection Centrifugation Filtration Impurity Precipitation Summary Capture Background Protein A Chromatography Chromatographic Methods Slurried Bed Methods Continuous Chromatography Capture Case Studies Continuous Protein A Chromatography Capture Case Study Effect of Clarification Method on Protein A Performance Polishing Background Technology Selection Strategy Complete Flow-Through Polishing Case Study Cost of Goods Analysis Methodology Clarification Capture Polishing Overall Summary 92 References 93 5 Modeling of Protein Monomer/Aggregate Purification by Hydrophobic Interaction Chromatography: Application to Column Design and Process Optimization 97 Mark-Henry Kamga, Hae Woo Lee, Namjoon Kim, and Seongkyu Yoon 5.1 Introduction Mathematical Model The Rate-Limiting Step in the HIC Process Dimensional Considerations Adsorption Capacity vs. Concentration of Vacant Sites (q mi vs. C vi ) Concentration of Protein Adsorbed on Resin (q i vs. C ia ) 100
4 VIII Mathematical Model Experimentation Protein Solutions Determination of Adsorption and Desorption Kinetic Constants Column Chromatography Results and Discussion Kinetic Constants Protein Denaturation Model vs. Experimental Results Applications Conclusion 112 Acknowledgments 112 References Continuous Animal Cell Perfusion Processes: The First Step Toward Integrated Continuous Biomanufacturing 115 Leda R. Castilho 6.1 Introduction The Basics of Perfusion Processes Cell Banking and Inoculum Development in the Context of Perfusion Processes Culture Conditions Cell Retention Devices Gravitational Settlers Centrifuges Hydrocyclones Acoustic (Ultrasonic) Separators Tangential Flow-Filtration ATF Systems Floating Membrane Devices Spin-Filters Rotating Cylindrical Filters (Vortex-Flow Filters or External Spin-Filters) Rotating Disc Filters (Controlled-Shear Filters) Integrated Perfusion Purification Processes for Continuous Biomanufacturing Concluding Remarks 144 References Perfusion Process Design in a 2D Rocking Single-Use Bioreactor 155 Nico M.G. Oosterhuis 7.1 Introduction Production Costs Equipment Requirements for a Single-Use Perfusion Process 157
5 IX 7.4 Testing Results Single-Use Perfusion Process Simplified Seeding Process Future Outlook 163 References Advances in the Application of Perfusion Technologies to Drosophila S2 Insects Cell Culture 165 Lars Poulsen and Willem A. de Jongh 8.1 Introduction Case Study 1: Acoustic Separation The Perfusion Setup (BioSep) Results and Discussion Development Cell Count in the Bioreactor Effects of BioSep Settings on Cell Loss and Viability Controlling the Cell Concentration Through Bleed Rate Control Effect of Total Dilution Rate on Culture Viability Development of the Perfusion Rate Profile Initial Testing of Robustness of Upstream Process in 1.5 l Fermentations Scaling Up and Consistency in 4.5 l Fermentations Process Scale-Up Conclusions for Case Study Case Study 2: ATF-Based Cell Retention ATF Technology Methods Results Cell Counts Achieved Using Perfusion Technology Effect of Feed Strategy Yield Improvements Achieved Using Fed-Batch and Concentrated Perfusion Protein Stability Conclusions for Case Study Final Remarks 181 Acknowledgments 181 References Single-Use Systems Support Continuous Bioprocessing by Perfusion Culture 183 William G. Whitford 9.1 Introduction Potential Advantages in Continuous Processing Improved Product Quality Ease in Process Development 188
6 X Improved Scalability Increased Profitability Sustainability Challenges in Adoption of Continuous Processing Continuous Biomanufacturing Single-Use Systems Hybrid Systems Perfusion Culture Single-Use in Continuous Biomanufacturing Roller Bottles Mechanically Agitated Suspension Reactors Hollow Fiber Media Exchange Packed Bed Bioreactors Hollow Fiber Perfusion Bioreactors Continuous Flow Centrifugation Acoustic Wave Separation Conclusion 222 References Multicolumn Countercurrent Gradient Chromatography for the Purification of Biopharmaceuticals 227 Thomas Müller-Späth and Massimo Morbidelli 10.1 Introduction to Multicolumn Countercurrent Chromatography Introduction to Multicolumn Simulated Moving Bed (SMB) Chromatography Capture Applications Introduction Process Principle Application Examples Polishing Applications Introduction Multicolumn Countercurrent Solvent Gradient Purification Principle Multicolumn Countercurrent Solvent Gradient Purification Process Design Multicolumn Countercurrent Solvent Gradient Purification Case Study Discovery and Development Applications Scale-Up of Multicolumn Countercurrent Chromatography Multicolumn Countercurrent Chromatography as Replacement for Batch Chromatography Unit Operations Multicolumn Countercurrent Chromatography in Continuous Manufacturing Process Analytical Tools for Multicolumn Countercurrent Processes 252 References 253
7 XI 11 Monoclonal Antibody Continuous Processing Enabled by Single Use 255 Mark Brower, Ying Hou, and David Pollard 11.1 Introduction Single-Use Revolution to Enable Process Intensification and Continuous Processing Principles of Continuous Multicolumn Chromatography for Biological Production (BioSMB) Continuous Downstream Processing for Monoclonal Antibodies Unit Operation Development Surge Vessels and Balancing Flows Primary Recovery: Centrifugation and Depth Filtration Bulk Purification: Continuous Multicolumn Chromatography BioSMB Protein A Capture and Viral Inactivation Protein A Loading Zone Optimization Protein A Elution Zone Considerations Viral Inactivation Fine Purification: Flow-Through Anion Exchange Chromatography (AEX) Effects of Sample Flow Rate on AEX Membrane Chromatography Effect of Sample Loading Amount on AEX Membrane Chromatography Scaling-Up Membrane Chromatography for Continuous Processing Fine Purification: Continuous Multicolumn Chromatography BioSMB Cation Exchange Chromatography Cation Exchange Loading Zone Optimization Cation Exchange Elution Zone Considerations Formulation: Continuous Ultrafiltration Pilot-Scale Demonstration of the Integrated Continuous Process Summary 293 References Continuous Production of Bacteriophages 297 Ales Podgornik, Nika Janez, Franc Smrekar, and Matjaz Peterka 12.1 Bacteriophages Life Cycle Determination of Bacteriophage Properties Bacteriophage Cultivation Chemostat Cellstat Cellstat Productivity Bacteriophage Selection Technical Challenges 323
8 XII 12.3 Continuous Purification of Bacteriophages Centrifugation Precipitation and Flocculation Filtration Chromatographic and Other Adsorption Methods Conclusions 329 References Very High Cell Density in Perfusion of CHO Cells by ATF, TFF, Wave Bioreactor, and/or CellTank Technologies Impact of Cell Density and Applications 339 Véronique Chotteau, Ye Zhang, and Marie-Francoise Clincke 13.1 Introduction Equipment Results and Discussion Perfusion Using ATF or TFF in Wave-Induced Bioreactor Cell Growth IgG Production Perfusion Using CellTank Cell Growth IgG Production Very High Cell Density Cryopreservation from Very High Cell Density Perfusion Conclusions 353 Acknowledgments 354 References Implementation of CQA (Critical Quality Attribute) Based Approach for Development of Biosimilars 357 Sanjeev K. Gupta 14.1 Background Biosimilar Product Development Attributes/Parameters in Biopharmaceuticals Critical Quality Attributes Critical Process Parameters (CPP) The ICH Q8 Minimal Approach to Pharmaceutical Development Quality-by-Design Quality Attributes and Biosimilars Development Quality, Safety, and Efficacy of Biosimilars Implementing CQA Approach for Biosimilar Development Identification of the CQA CQA-Based Clone Selection and Upstream Process Development Factors Affecting CQAs of the Biologics 366
9 XIII Expression Host and Recombinant Cell Line Process Related Protein Production Host and CQA Cell Line Changes and CQA Host Cell Line and Clone Selection Criteria Sequence Variants Identification by CQA Incomplete Processing of Signal Sequences and CQA Upstream Process Impact on Product Quality Attributes Bioreactor Optimization and Scale Up CQA in Purification and Formulation Downstream Processing of Biosimilars Downstream Processing and CQA CQAs in Formulation and Stability Formulation and Quality Attributes Stability and Quality Attributes Summary 382 References Automated Single-Use Centrifugation Solution for Diverse Biomanufacturing Process 385 Sunil Mehta 15.1 Introduction Separation by Centrifugation Separation by Filtration Downstream Process Challenges of High Cell Density Cultures Single-Use Centrifugation ksep Technology ksep System Configuration Low-Shear Process Perfusion Concentration, Media Replacement, and Harvest of Cells Continuous Harvest Clarification Separation of Cells from Microcarriers Summary 399 References The Review of Flexible Production Platforms for the Future 401 Maik W. Jornitz 16.1 Introduction Today s Processing Technology Advances Single-Use Liquid Hold and Mixing Bags Filtration and Purification Technologies Product and Component Transfer Aseptic Fluid Connections and Disconnections Single-Use Final Filling Systems 417
10 XIV 16.3 Todays Facility Designs Construction and Design Types Process Location and Flow Future Processing and Facility Requirements Upstream Technologies Downstream Technologies Single-Use Engineering and Design Facilities and Process Design 428 References Evaluating the Economic and Operational Feasibility of Continuous Processes for Monoclonal Antibodies 433 Suzanne S. Farid, James Pollock, and Sa V. Ho 17.1 Introduction Background on Continuous Processing Perfusion Culture Semicontinuous Chromatography Tool Description Case Study 1: Fed-batch Versus Perfusion Culture for Commercial mab Production Case Study 2: Semicontinuous Affinity Chromatography for Clinical and Commercial Manufacture Case Study 3: Integrated Continuous Processing Flowsheets Conclusions 452 Acknowledgments 452 References Opportunities and Challenges for the Implementation of Continuous Processing in Biomanufacturing 457 Sadettin S. Ozturk 18.1 Introduction A Brief History of Continuous Processing in Biomanufacturing Opportunities for Continuous Processing in Biomanufacturing Higher Process Yields Higher Process Efficiencies Compact and Flexible Facilities Stable and Consistent Production Better Product Quality Challenges for Implementing Continuous Processing in Biomanufacturing Process Complexity Cell Retention High Cell Density Longer Run Times Process Scalability in a Continuous Perfusion Process 470
11 XV Scale and Capacity Limitations Process Scale-up Process Consistency and Control Process Characterization and Validation Complexity of a Scale-down Model for a Perfusion Process Process Optimization and Characterization for a Perfusion Process Process Validation Conclusions 476 Acknowledgment 476 References The Potential Impact of Continuous Processing on the Practice and Economics of Biopharmaceutical Manufacturing 479 L. Richard Stock, Marc Bisschops, and Thomas C. Ransohoff 19.1 Introduction Background (Review of Status Quo How We Make Biopharmaceutical Products Today) The Rationale for Continuous Processing The Obstacles for Implementation of Continuous Processing for Biopharmaceuticals The Potential Impact of Continuous Manufacturing on Process Economics The Potential Impact of Continuous Processing on Biopharmaceutical Manufacturing Practices Summary 492 References 492 Index 495
12
Bioprocessing Challenges: High-Titer Mammalian-Based Cell Systems. Elements influencing the way Biologics may be manufactured /supplied in the future
Bioprocessing Challenges: High-Titer Mammalian-Based Cell Systems Jonathan Romero CMC Leadership, Technical Development Pharmaceutical Operations & Technology 2015 ISPE PRODUCT SHOW Business Drivers Elements
More informationEmerging and Enabling Technologies in Membrane Separations
Emerging and Enabling Technologies in Membrane Separations Andrew L. Zydney Distinguished Professor of Chemical Engineering The Pennsylvania State University 2 nd International Symposium on Continuous
More informationWelcome Biotech 101. Outline. Before the Floor. Manufacturing Process. Supporting Cast 4/22/2013
Welcome Biotech 101 Outline Before the Floor All the activities that happen before large scale cgmp manufacturing Manufacturing Process Manufacturing steps Equipment Requirements How it all works together
More informationContinuous Purity Technological, Regulatory and Validation Considerations for single-use continuous downstream processing
Marc Bisschops Tarpon Biosystems Inc. Continuous Purity Technological, Regulatory and Validation Considerations for single-use continuous downstream processing Integrated Continuous Biomanufacturing Castelldefels
More informationCONTINUOUS MANUFACTURING FOR BIOLOGICS & VACCINES
CONTINUOUS MANUFACTURING FOR BIOLOGICS & VACCINES Sue Behrens ISPE Product Show Track 2, Session 3 September 26, 2018 Questions about Continuous Bioprocessing Why? What s next? 2 1 Sue Behrens - Intro
More informationPerfusion and Beyond The XCell TM ATF System
Perfusion and Beyond The XCell TM ATF System Earl Pineda Field Application Scientist Web ads May 9, 2018 Inspiring advances in bioprocessing since 1985 Repligen Corporation: one of the fastest-growing
More informationProcess Removal of Impurities in Biotech Products
Process Removal of Impurities in Biotech Products CASSS Midwest Regional Forum October 5, 2017 Warren R. Emery Sr. Research Scientist Bioproduct R&D, Eli Lilly and Company Pharmaceutical Process Development
More informationTraining Program 2019
www.bcc.ch info@bcc.ch Biofactory Competence Center SA Passage du Cardinal 13b 1700 Fribourg (CH) Training Program 2019 Training is delivered by subject matter experts from both academia and those with
More informationContinuous Biomanufacturing: Relevant Experiences with Development, Hybrid Implementation, and Emerging Opportunities
Continuous Biomanufacturing: Relevant Experiences with Development, Hybrid Implementation, and Emerging Opportunities Erik Fouts, Ph.D. VP and Site Head, Novato Operations 3-4 December ASTM E2968 14 Continuous
More informationSubject Index. chromatography step, 125-
A Alert limits, description, 70 Aluminum hydroxide based vaccine manufacture, start up and validation of sterile formulation and filling processes, 144-168 Anion-exchange chromatography step for clinical-grade
More informationSubject Index. See for options on how to legitimately share published articles.
Downloaded via 148.251.232.83 on March 27, 2019 at 03:59:27 (UTC). See https://pubs.acs.org/sharingguidelines for options on how to legitimately share published articles. A Alert limits, description, 70
More informationContinuously Improving Bioprocesses: Biopharmaceutical Capabilities
Continuously Improving Bioprocesses: Biopharmaceutical Capabilities Pall Corporation A Legacy of Innovation Dr. David B. Pall Founded by Dr. David B. Pall in 1946, Pall Corporation has grown from a company
More informationEmerging and Enabling Technologies in Chromatography of Integrated Biomanufacturing
Emerging and Enabling Technologies in Chromatography of Integrated Biomanufacturing Steven M. Cramer Isermann Department of Chemical and Biological Engineering Center for Biotechnology and Interdisciplinary
More informationOperational & Economic Evaluation of Integrated Continuous Biomanufacturing Strategies for Clinical & Commercial mab Production
UCL Decisional Tools Research Operational & Economic Evaluation of Integrated Continuous Biomanufacturing Strategies for Clinical & Commercial mab Production Suzanne Farid PhD CEng FIChemE Reader (Associate
More informationOperational & Economic Evaluation of Integrated Continuous Biomanufacturing Strategies for Clinical & Commercial mab Production
UCL Decisional Tools Research Operational & Economic Evaluation of Integrated Continuous Biomanufacturing Strategies for Clinical & Commercial mab Production Suzanne Farid PhD CEng FIChemE Reader (Associate
More informationThe use of Chromatography Membranes for the development and production of biopharmaceuticals.
The use of Chromatography Membranes for the development and production of biopharmaceuticals. Dr. Juan Pablo Acosta Martinez Project Manager. Virus and Contaminant Clearance Sartorius Stedim Biotech Agenda
More informationFast Trak Services: Ongoing collaboration aims to accelerate biosimilar approval in China
GE Healthcare Fast Trak Services: Ongoing collaboration aims to accelerate biosimilar approval in China A case study Fast Trak Services Ongoing collaboration aims to accelerate biosimilar approval in China
More informationTo be Continuous or Discontinuous, that is the Question
E2E Integrated Continuous Manufacture of Therapeutic Proteins: Key Technologies Needed and Lessons Learned To be Continuous or Discontinuous, that is the Question Charles L. Cooney Robert T. Haslam (1911)
More informationContinuous Processing Progress in Manufacturing
Cell World Conference, San Francisco, May 25-26 2017 Dr. Berthold Boedeker, Bayer AG, Biological Development Biologics at Bayer Regulatory support / drivers aof continuous processing Bayer s approach to
More informationFast Trak Services: Long-term collaboration supports speed to market in single-use biomanufacturing
GE Healthcare Fast Trak Services: Long-term collaboration supports speed to market in single-use biomanufacturing A case study Fast Trak Services Long-term collaboration supports speed to market in single-use
More informationPROCESS SCALE PURIFICATION OF ANTIBODIES Edited by UWE GOTTSCHALK Group Vice President Purification Technologies Sartorius Stedim Biotech A JOHN WILEY & SONS, INC., PUBLICATION PROCESS SCALE PURIFICATION
More informationRecent Developments & Future Directions in the Production of Monoclonal Antibodies. Rob Noel Plasma Product Biotechnology Conference 2009, Menorca
Recent Developments & Future Directions in the Production of Monoclonal Antibodies Rob Noel Plasma Product Biotechnology Conference 2009, Menorca Forecast sales by molecule type ($m), 2006 12 600,000 Pharmaceuticals
More informationContinuous mab Purification Process: Design Features and Practical Considerations
Continuous mab Purification Process: Design Features and Practical Considerations Joanna Pezzini CASSS DC Area Discussion Group Meeting December 7, 2017 Outline Continuous Process Overview Continuous Technologies
More informationHistorically, in generating
FOCUS ON... BUSINESS Standardized Economic Cost Modeling for Next-Generation MAb Production David Pollard, Mark Brower, Yuki Abe, Adriana G. Lopes, and Andrew Sinclair Historically, in generating material
More informationDownstream processing is a
V E N D O RVoice Multicolumn Chromatography A New Approach to Relieving Capacity Bottlenecks for Downstream Processing Efficiency Margit Holzer, Hector Osuna-Sanchez, and Laurent David Downstream processing
More informationLFB BIOMANUFACTURING YOUR CDMO PARTNER FOR MABS AND RECOMBINANT PROTEINS B IOMANUFACTURING
YOUR CDMO PARTNER FOR MABS AND RECOMBINANT PROTEINS B IOMANUFACTURING COMMITMENT AND FLEXIBILITY LFB BIOMANUFACTURING is a medium-sized CDMO offering Bioproduction services, from an industrial facility
More informationPresented at the ECI Conference on Integrated Continuous Biomanufacturing Castelldefels, Spain, October 21, 2013
Continuous Antibody Capture with Protein A Countercurrent Tangential Chromatography: A New Column-Free Approach for Antibody Purification Andrew L. Zydney Department Head and Walter L. Robb Family Chair
More informationPhenyl Membrane Adsorber for Bioprocessing
Phenyl Membrane Adsorber for Bioprocessing Sartobind Hydrophobic Interaction Membrane Chromatography The low substitution of the phenyl ligand on the membrane allows for mild elution of biomolecules such
More informationThe Eshmuno Chromatography Family of Resins
The Eshmuno Chromatography Family of Resins The perfect accessory for highly productive downstream purification EMD Millipore is a division of Merck KGaA, Damstadt, Germany Introduction For over 300 years,
More informationNew technologies in biopharmaceutical processes BioTech Vaccines Plasma
New technologies in biopharmaceutical processes BioTech Vaccines Plasma Dominik Arnold dominik_arnold@pall.com Challenges in Down Stream Processing Higher. Titers >4 g/l Yield > 90% Protein concentration
More informationDevelopment from Bench to Clinic
Accelerating Novel Vaccine Development from Bench to Clinic Roger Lias. Ph.D. President Eden Biodesign, Inc Questions Questions are encouraged and can be asked by sending an email to: edenbiodesign@propelmg.com
More informationEnd-to-End Integrated Continuous Manufacture of Monoclonal Antibodies
End-to-End Integrated Continuous Manufacture of Monoclonal Antibodies Fabian Steinebach, Daniel Karst, Massimo Morbidelli, ETH Zurich 11/17/216 1 Continuous Integrated Production Opinion: Higher demands
More informationPhenyl Membrane Adsorber for Bioprocessing
Phenyl Membrane Adsorber for Bioprocessing Sartobind Hydrophobic Interaction Membrane Chromatography The low substitution of the phenyl ligand on the membrane allows for mild elution of biomolecules such
More informationAdsorptive and Mechanical Mechanisms of Fluid Purification Using Charge Modified Depth Filtration Media. Dr. Robert Conway, Ph.D.
Adsorptive and Mechanical Mechanisms of Fluid Purification Using Charge Modified Depth Filtration Media Dr. Robert Conway, Ph.D. Depth Filter Cartridge Construction Zeta Plus Media Materials of Construction
More informationCHO-GSN PLATFORM STABLE CELL LINE GENERATION. NR v5
CHO-GSN PLATFORM STABLE CELL LINE GENERATION NR3160 20180122 v5 Highlights of LakePharma s CHO-GSN Cell Line Platform 2 LakePharma proprietary technology Complete cell line lineage and clear path to commercialization,
More informationImplementing Continuous Chromatography into DSP of Bio-Molecules
into DSP of Bio-Molecules 2014 Prep Symposium in Boston, MA Kathleen Mihlbachler Global Director of Separations Development LEWA Process Technologies kmihlbachler@lewapt.com Objective Improve the economical,
More informationInnovative technologies and methods in supporting continuous Biomanufacturing
World Biopharm 2015_A5 Proof 8 10/03/15 9:21 WORLD BIOPHARM FORUM 2015 Innovative technologies and methods in supporting continuous Biomanufacturing Robinson College, Cambridge, UK 23rd-24th June, 2015
More informationModular Retrovirus Clearance in Support of Clinical Development
Modular Retrovirus Clearance in Support of Clinical Development Bio-product Research & Development, Eli Lilly and Company CMC Strategy Forum, Europe, 2018 D. Chen/ M. Murphy General Expectations for Viral
More informationAbstract Process Economics Program Report 188B BIOTECHNOLOGY SEPARATION PROCESSES (June 2002)
Abstract Process Economics Program Report 188B BIOTECHNOLOGY SEPARATION PROCESSES (June 2002) The chemical industry has a renewed interest in developing processes for producing industrial chemicals from
More informationInspiring Advances in Bioprocessing. John Bonham-Carter March 14, 2017
Inspiring Advances in Bioprocessing John Bonham-Carter March 14, 2017 Bioprocessing Trends Emerging trends, new challenges Integrated continuous processing Upstream continuous processing (perfusion) proven
More informationSingle use plastic settlers for clarifying cell culture broth, selective removal of dead cells and affinity capture of antibodies on protein A beads
Engineering Conferences International ECI Digital Archives Single-Use Technologies III: Scientific and Technological Advancements Proceedings 9-23-2018 Single use plastic settlers for clarifying cell culture
More informationIntegrated Continuous Bioprocessing: Economic, Operational, and Environmental Feasibility for Clinical and Commercial Antibody Manufacture
Integrated Continuous Bioprocessing: Economic, Operational, and Environmental Feasibility for Clinical and Commercial Antibody Manufacture James Pollock Dept. of Biochemical Engineering, University College
More informationApplication of Disposable Technologies in Biopharmaceutical Manufacturing
BMD Summit, Disposables for Biopharm Production 13th December 2005 Reston, VA, USA Application of Disposable Technologies in Biopharmaceutical Manufacturing Martin Wrankmore, Continuous Improvement Lead,
More informationFuture Perspectives of Antibody Manufacturing
BioProduction 2005 Amsterdam Future Perspectives of Antibody Manufacturing John Birch Lonza Biologics Monoclonal Antibodies A Success Story Fastest growing segment of the pharmaceutical market Sales forecast
More informationThe amazing ability of continuous chromatography to adapt to a moving environment.
The amazing ability of continuous chromatography to adapt to a moving environment. Roger-Marc Nicoud, Founder of Novasep Barcelona, October 2013 Introduction My thesis: the environment pressure pushes
More information3. Close the bottom end of the column and apply the packing device on top. Pump water through the upper adaptor to remove air.
INSTRUCTIONS FOR USE WorkBeads Protein A Product name Pack size Article number WorkBeads Protein A Bulk Media 1.5 ml 40605001 Bulk Media 5 ml 40605002 Bulk Media 10 ml 40605003 Bulk Media 100 ml 40605004
More informationDisposable Technologies for Purification of Biopharmaceuticals
Disposable Technologies for Purification of Biopharmaceuticals Thomas C. Ransohoff BioProcess Technology Consultants, Inc. NE Society for Industrial Microbiology Winter Meeting Boston, MA December 14,
More informationDevelopment. - Be Your Partner-
Development - Be Your Partner- 1 Product development and management 2 Product development and management A good product development is based on a strong product management. Mycenax sproject management
More informationDOWNSTREAM PROCESSING OF MONOCLONAL ANTIBODIES: CURRENT PRACTICES AND FUTURE OPPORTUNITIES. Brian Kelley, Greg Blank, and Ann Lee
1 DOWNSTREAM PROCESSING OF MONOCLONAL ANTIBODIES: CURRENT PRACTICES AND FUTURE OPPORTUNITIES Brian Kelley, Greg Blank, and Ann Lee 1.1 INTRODUCTION Monoclonal antibodies (mabs) are now established as the
More informationContents. Preface XI Nomenclature XIII. Part I Basic Concepts and Principles 1
V Preface XI Nomenclature XIII Part I Basic Concepts and Principles 1 1 Introduction 3 1.1 Background and Scope 3 1.2 Dimensions and Units 4 1.3 Intensive and Extensive Properties 6 1.4 Equilibria and
More informationThe Future is NOW for Continuous Manufacturing Part 3 Multi Column Continuous (MCC) Chromatography
The Future is NOW for Continuous Manufacturing Part 3 Multi Column Continuous (MCC) Chromatography Dr. Kathleen Mihlbachler Global Director of Separation Development LEWA Process Technologies 15 01 2015
More informationSimplicity is the key Continuous purification of monoclonal antibodies
Simplicity is the key Continuous purification of monoclonal antibodies L. Landric-Burtin Head of Downstream Processing Development, France Integrated Continuous Biomanufacturing Conference, Barcelona,
More informationIntensification of a Perfusion Platform using Single-use XCell ATF Systems
Intensification of a Perfusion Platform using Single-use XCell ATF Systems Olaf Mol Sr. Bioprocess Scientist The world leader in serving science Global Footprint- Biologics Princeton, USA PD Center of
More informationMonoclonal antibody (MAb)
B i o P r o c e s s TECHNICAL Author Insights Online Exclusive www.bioprocessintl.com/bpiextra Cost Estimation for Protein A An In Silico Approach to MAb Purification Strategy Matthias Franzreb, Egbert
More informationFuture biologics manufacturing
Future biologics manufacturing Process integration with single-use technology Dr. Günter Jagschies Senior Director, Strategic Customer Relations GE Healthcare Life Sciences Uppsala, Sweden Mammalian Cell
More informationViral vectors Overcoming process. Dave Simpson PhD Process Development Manager
Viral vectors Overcoming process challenges to meet the clinical demands Dave Simpson PhD Process Development Manager Eden Biodesign Ltd Questions Questions are encouraged throughout the presentation and
More informationDownsizing downstream processing: A novel single-use purification platform for biologics
Downsizing downstream processing: A novel single-use purification platform for biologics James Stout, PhD VP, Process Sciences BPI Boston, October 2015 Natrix Separations Inc. Burlington, Ontario, Canada
More informationPreparative Protein Chemistry
Biochemistry 412 Preparative Protein Chemistry 19 February 2008 The Three Eras of Protein Purification 1. The Classical (Pre-Recombinant DNA) Era (pre-1978) - Proteins purified from natural sources only
More informationBPI.Seminar Semina opelmg ropelmg.com com
Send questions to: BPI.Seminars@propelmg.com Moving to the next level of Manufacturing Oct 14 th 2009 BPI Raleigh Rolf Douwenga VP Global Research and Development DSM Biologics. DSM CONFIDENTIAL FL15 Agenda
More informationGuideline on process validation for the manufacture of biotechnology-derived active substances and data to be provided in the regulatory submission
1 2 3 25 April 2014 EMA/CHMP/BWP/187338/2014 Committee for Medicinal Products for Human Use (CHMP) 4 5 6 7 Guideline on process validation for the manufacture of biotechnology-derived active substances
More informationIn the biopharmaceutical industry,
S i n g l e - U s e TECHNOLOGIES Continuous Cell Culture Operation at 2,000-L Scale Michael Sherman, Vincent Lam, Melissa Carpio, Nick Hutchinson, and Christel Fenge In the biopharmaceutical industry,
More informationHarvesting Technology Guide for mab Processes. Accelerated process development through the identification of optimal platform solutions
Harvesting Technology Guide for mab Processes Accelerated process development through the identification of optimal platform solutions 3 Accelerate Your Process Development Your guide to cell harvesting
More informationAn Indian Journal FULL PAPER ABSTRACT KEYWORDS. Trade Science Inc. Primary recovery of mammalian cell culture. [Type text] [Type text] [Type text]
[Type text] [Type text] [Type text] ISSN : 0974-7435 Volume 10 Issue 24 BioTechnology 2014 An Indian Journal FULL PAPER BTAIJ, 10(24), 2014 [16201-16206] Primary recovery of mammalian cell culture Tiju
More informationDownstream Processing in Biopharmaceuticals
Downstream Processing in Biopharmaceuticals Adoption of Disposable Technology at Improved Economies of Scale to Optimize Production Efficiency and Cost-effectiveness GBI Research Report Guidance GBI Research
More informationUnlike chemically synthesized
Continuous Processing TECHNOLOGIES Using Technology to Overcome Bioprocessing Complexity Advanced Concentration and Analytical Technologies Accelerate Development and Manufacture of mabs, Vaccines, and
More informationPurification Strategy for Antibodies in partnership with Mannheim University of Applied Sciences
Chromatography Purification Strategy for Antibodies in partnership with Mannheim University of Applied Sciences Putting theory into practice In today s evolving workplace, it is vital to understand why
More informationSingle-use technology and sustainability: quantifying the environmental impact
Single-use technology and sustainability: quantifying the environmental impact Bill Flanagan Director, Ecoassessment Center of Excellence, GE 1 November 2016 Imagination at work Agenda Biopharmaceutical
More informationTools and solutions for separation of charged mab variants
GE Healthcare Tools and solutions for separation of charged mab variants A biosimilar is an almost identical version of an originator product, but to attain regulatory approval, a comparable quality to
More informationJapanese Application Form: PMDA s Perspective on Manufacturing Process Description
Japanese Application Form: PMDA s Perspective on Manufacturing Process Description Reiko YANAGIHARA, Ph.D. Principal Reviewer Division of Pharmacopoeia and Standards for Drugs Office of Standards and Guideline
More informationAseptic Sampling Best Practices Endotoxin Binding Affinity
Aseptic Sampling Best Practices Endotoxin Binding Affinity Scope Technical Note This technical report describes a study to evaluate binding affinity of Control Standard Endotoxin (CSE) to different plastic
More informationPharmaceutical. The impact of continuous multicolumn chromatography on biomanufacturing efficiency. Review. Marc Bisschops* 1 & Mark Brower 2 1
Pharmaceutical Pharm. Bioprocess. (2013) 1(4), 361 372 The impact of continuous multicolumn chromatography on biomanufacturing efficiency Over the past few years, the capacity bottleneck in biomanufacturing
More informationEvaluating facility design and capacity planning decisions for clinical and commercial supply with hybrid continuous processes
Engineering Conferences International ECI Digital Archives Integrated Continuous Biomanufacturing II Proceedings Fall 11-2-2015 Evaluating facility design and capacity planning decisions for clinical and
More informationEconomic Impact of Single-Use Bioreactors
Economic Impact of Single-Use Bioreactors Rick Stock 2012 BIO International Convention BioProcess Theater Presentation Upstream Processing Boston, MA June 19th, 2012 BioProcess Technology Consultants www.bptc.com
More informationReducing Total Cost Of Ownership In Media Filtration. White Paper. by Mandar Dixit and Chris Sullivan
Reducing Total Cost Of Ownership In Media Filtration White Paper by Mandar Dixit and Chris Sullivan Contents 3 Overview 4 Drawbacks of Existing Filter Membranes 5 New PES Membrane Technologies Specific
More informationEvaluation of novel CEX resin for continous processing of MAb purification
Engineering Conferences International ECI Digital Archives Integrated Continuous Biomanufacturing II Proceedings Fall 11-2-2015 Evaluation of novel CEX resin for continous processing of MAb purification
More informationProtein Methods. Second Edition. DANIEL M. BOLLAG Merck Research Laboratories West Point, Pennsylvania
Protein Methods Second Edition DANIEL M. BOLLAG Merck Research Laboratories West Point, Pennsylvania MICHAEL D. ROZYCKI Department of Chemistry The Henry H. Hoyt Laboratory Princeton University Princeton,
More informationTrends in Perfusion Bioreactors: Will Perfusion Be the Next Revolution in Bioprocessing? June 15, 2011 BioProcess International
Trends in Perfusion Bioreactors: Will Perfusion Be the Next Revolution in Bioprocessing? June 15, 2011 BioProcess International Single-use/disposable bioprocessing equipment has come to thoroughly dominate
More informationMONOCLONAL ANTIBODIES AND BIOSIMILARS production, naming, pharmacovigilance and other pharmaceutical quality aspects
1 MONOCLONAL ANTIBODIES AND BIOSIMILARS production, naming, pharmacovigilance and other pharmaceutical quality aspects Prof. dr. Jos G.W. Kosterink Department of Clinical Pharmacy and Pharmacology University
More informationPeriodic countercurrent (PCC)
B i o P r o c e s s TECHNICAL Scale-Up of Twin-Column Periodic Counter-Current Chromatography for MAb Purification James Angelo, John Pagano, Thomas Müller-Späth, Kathleen Mihlbachler, Srinivas Chollangi,
More informationSummer Training Program In Industrial Biotechnology BiOZEEN, Bangalore
Summer Training Program In Industrial Biotechnology BiOZEEN, Bangalore BiOZEEN Summer Training Program in Industrial Microbiology & Fermentation Technology One small step can brighten your future Microbes
More informationOptimization of Protein Purification Using Small-Scale Separation Columns
Optimization of Protein Purification Using Small-Scale Separation Columns Chris Suh, Ph.D Application Scientist, Inc. San Jose, Ca 2 nd Therapeutics & Drug Discovery Conference Presentation Outline 1.
More informationModular DSP approaches for complex non-mab molecules
Modular DSP approaches for complex non-mab molecules Dr. Stefan R. Schmidt MBA SVP Process Science & Production Agenda 1 Introduction 2 3 4 5 Process related impurities Product related impurities Virus
More informationCalendar. The Clear Solution to Reach the Global Biopharma Audience. INTERNATIONAL
The Clear Solution to Reach the Global Biopharma Audience yvdavyd/getty Images & blackred/e+/getty Images 2017 EDITOrial Calendar Editorial Coverage Special Themed Issues January Biopharma Outlook for
More informationChromatography column for therapeutic protein analysis
PRODUCT SPECIFICATIONS ProPac Elite WCX Column Chromatography column for therapeutic protein analysis Benefits Superior resolution power for proteins, monoclonal antibodies, and associated charge variants
More informationContents. 01 Introduction to Continuous Manufacturing: Technology Landscape and Trends. 02 A Brief History of Perfusion Biomanufacturing
Contents 01 Introduction to Continuous Manufacturing: Technology Landscape and Trends Eric S. Langer & Ronald A. Rader, BioPlan Associates 02 A Brief History of Perfusion Biomanufacturing Jerry Shevitz
More informationDeveloping an Appropriate Design Space Strategy to Mitigate Variability in Downstream Processing Operations
1 Developing an Appropriate Design Space Strategy to Mitigate Variability in Downstream Processing Operations Justin McCue Biogen Idec Corporation September, 2010 1 2 Overview Chromatography column scale
More informationChromatography for the Bio processing Industry
A Technical Journal of the ASME Bioprocessing Equipment Standard Chromatography for the Bio processing Industry Developed and Written by BPE Subject Matter Experts For names of contributors refer to pag
More informationWorkBeads Protein A INSTRUCTIONS IN
WorkBeads Protein A INSTRUCTIONS IN 40 605 010 WorkBeads Protein A resin is designed for the purification of monoclonal and polyclonal antibodies using affinity chromatography. For small scale purification
More informationGE Healthcare Life Sciences. Plug & Play. ReadyToProcess. Ready-to-use technologies for greater speed and agility in bioprocessing.
GE Healthcare Life Sciences Plug & Play ReadyToProcess. Ready-to-use technologies for greater speed and agility in bioprocessing. Imagine & Lead Biopharmaceutical development and manufacturing demands
More informationHigh Throughput Screening Technologies for developing purification processes of proteins. Michel Eppink, Synthon BV, Nijmegen
High Throughput Screening Technologies for developing purification processes of proteins Michel Eppink, Synthon BV, Nijmegen Introduction Overview From small to large processes New protein purification
More informationBiotechnology: Quality Assurance and Validation
r Biotechnology: Quality Assurance and Validation Drug Manufacturing Technology Series Volume 4 Kenneth E. Avis Carmen M. Wagner Vincent L. Wu Editors Interpharm Press, Inc. Buffalo Grove, Illinois CONTENTS
More informationIntroduction to Biotechnology and Bioprocess Engineering A Course for the Chemical Engineering Curriculum
Introduction to Biotechnology and Bioprocess Engineering A Course for the Chemical Engineering Curriculum Michael Gyamerah and Irvin W. Osborne-Lee, Chemical Engineering Department, Prairie View A&M University,
More informationManufacturing Integrated Biologics Manufacturing
Manufacturing Integrated Biologics Manufacturing Integrated Biologics Manufacturing Abzena provides customer focused process development and manufacturing services for cgmp and non-gmp production of recombinant
More informationTransition to Next Gen Downstream Processing to Capitalize on Growth Opportunities in High-Value Low-Volume Biologics
A Virtual Think Tank Executive Summary Transition to Next Gen Downstream Processing to Capitalize on Growth Opportunities in High-Value Low-Volume Biologics By: Unmesh Lal, Program Manager, Transformational
More informationCBB s Research and Process Development Laboratory (RPD) Equipment List. Table 1: List of Fermentors
CBB s Research and Process Development Laboratory (RPD) Equipment List Table 1: List of Fermentors Image Working Volume (Lit) Model Typical Use/Comments 1 DasGip DASGIP Parallel Bioreactor Systems for
More informationFiltration of Cell Culture Growth Media and Process Buffers
Customer Application Brief Bioprocess, Biologicals, & Pharmaceutical Filtration of Cell Culture Growth Media and Process Buffers Introduction Media feeds and process buffers are two universal additives
More informationsingle-use fermentors
Thermo Scientific HyPerforma Single-Use Fermentors Purpose-built single-use fermentors Designed for the unique requirements of microbial fermentation Designed to meet your needs The new Thermo Scientific
More informationVirus Filtration for Biosimilars : From needs to Solutions
Virus Filtration for Biosimilars : From needs to Solutions 3 rd International Conference and Exhibition on Biowaivers, Biologics and Biosimilars - Hyderabad Tathagata Ray Layout of Presentation 1 Virus
More informationKeeping up with Single-Use Geoffrey Hodge SVP Operations Unum Therapeutics 07 Oct 15
Keeping up with Single-Use Geoffrey Hodge SVP Operations Unum Therapeutics 07 Oct 15 Outline Introduction / Overview Technology Survey Economics Quality Single Use Facilities Summary 1 Introduction Disclaimer
More informationSCIENTIFIC. Process for Success. CHO ONE Media System. Expression Media for Fed-Batch Culture
CAPRICORN SCIENTIFIC Process for Success CHO ONE Media System Expression Media for Fed-Batch Culture Culture for Life www.capricorn-scientific.com 2 Capricorn Scientific as a young established cell culture
More information